{"id":358,"date":"2025-04-16T14:40:20","date_gmt":"2025-04-16T11:40:20","guid":{"rendered":"https:\/\/en.iepor.site\/?page_id=358"},"modified":"2026-03-04T21:14:16","modified_gmt":"2026-03-04T18:14:16","slug":"oncologica","status":"publish","type":"page","link":"https:\/\/en.iepor.site\/?page_id=358","title":{"rendered":"ONcoLogiCa"},"content":{"rendered":"<div class=\"wp-block-html\">\n<div style=\"font-family: Arial, sans-serif; font-size: 16px; color: #333; line-height: 1.6;\">\n<h2 style=\"font-size: 24px; font-weight: bold; text-align: center;\">ABOUT THE PROJECT<\/h2>\n<p>The ONcoLogi\u0421a project is an initiative by the Council of Young Scientists at the R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology of the National Academy of Sciences of Ukraine. It aims to promote modern knowledge and advancements in oncology. The project&#8217;s goal is to unite researchers, doctors, postgraduate students, as well as students of biological and medical faculties to discuss the most pressing issues in the fight against cancer, exchange experiences, and enhance professional knowledge.<\/p>\n<p>As part of the ONcoLogi\u0421a project, a series of seminars, lectures, and training sessions will be held, covering modern methods of cancer diagnosis, treatment, and prevention, molecular oncology, immunotherapy, genetic research, and other innovative fields.<\/p>\n<p>Participation in the ONcoLogi\u0421a project will help postgraduate students studying in biomedical institutions deepen their knowledge, familiarize themselves with the latest fundamental and applied scientific trends, and find inspiration for their own research. The project\u2019s implementation will foster interdisciplinary collaboration and attract talented young scientists to research activities.<\/p>\n<p>Join our project to advance Ukrainian science together and contribute to the fight against cancer!<\/p>\n<h3 style=\"margin-top: 30px; font-size: 20px;\">LECTURES<\/h3>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">\u00abThe Role of DNA Viruses in Carcinogenesis\u00bb.<\/h4>\n<p>Malignant tumors differ from normal cells in their ability to proliferate uncontrollably, evade cell death, and disrupt regulatory mechanisms governing cellular function. This lecture addresses the question of whether microorganisms can contribute to the development of cancer. The audience will be introduced to the history of the discovery of oncogenic viruses, including the pioneering work of Wilhelm Ellermann, Oluf Bang, and Peyton Rous, who demonstrated that viruses are capable of initiating tumor formation in animals. Particular attention will be devoted to tumorigenic DNA viruses that are directly involved in malignant cellular transformation, especially through mechanisms involving the inactivation of tumor suppressor genes that regulate proliferative activity. Classical examples of such viruses will be discussed, including the Luck\u00e9 tumor virus in frogs, Marek\u2019s disease herpesvirus in poultry, simian virus 40 (SV40), and adenoviruses, as well as their role in the molecular mechanisms of carcinogenesis. The oncogenic potential of human herpesviruses will also be addressed separately. The lecture further highlights vaccination as an effective tool for the prevention of virus-associated cancers. Using human papillomavirus (HPV) as an example, it will be demonstrated how immunoprophylaxis can significantly reduce the incidence of oncological diseases.<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/en.iepor.site\/wp-content\/uploads\/2026\/03\/Elena-Kashuba.png\" alt=\"Elena Kashuba\" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Elena Kashuba<\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\nDoctor of Biological Sciences, Professor, Head of the Laboratory of Molecular Mechanisms of Cell Transformation<br \/>\nR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">Cell Culture in Experimental Oncology.<\/h4>\n<p>Cell culture models are among the key experimental systems used to investigate the molecular-genetic and cellular mechanisms of carcinogenesis. The development and application of cell cultures have made it possible to study the effects of antitumor agents of various origins, ranging from conventional chemotherapeutic drugs to modern targeted and biological therapies. This lecture will focus on the fundamental principles of cell cultivation and contemporary methods of cellular analysis, illustrated by examples of leukemia and prostate cancer cell lines.<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/en.iepor.site\/wp-content\/uploads\/2026\/03\/Svitlana-Antonenko.png\" alt=\"Svitlana Antonenko \" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Svitlana Antonenko <\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\nPhD, Senior Researcher, <br \/>\nDepartment of Molecular Genetics<br \/>\nInstitute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">Mechanisms of Cell Movement and Methods of Their Investigation.<\/h4>\n<p>Cell migration is one of the fundamental biological processes underlying embryonic development, wound healing, immune responses, and tumor metastasis. Studying the mechanisms of cell movement provides insight into how alterations in the cytoskeleton, cell adhesion, and signaling pathways determine cellular behavior under both physiological and pathological conditions. The lecture will address how cells migrate, why this process is essential, and how and why it is studied in experimental research.<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/en.iepor.site\/wp-content\/uploads\/2026\/03\/Anastasiia-Hubiernatorova.png\" alt=\"Anastasiia Hubiernatorova\" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Anastasiia Hubiernatorova<\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\nPhD, Laboratory of Tissue Morphogenesis and Cancer<br \/>\nInstitute of Molecular Genetics, Czech Academy of Sciences\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">The Concept of the Three \u201cC\u201ds: Current Perspectives and Future Directions in Immunotherapy. <\/h4>\n<p>The emergence and progression of malignant neoplasms are determined by the complexity of interactions between the tumor and the host organism. The immune system plays a key role in these processes, ensuring antigenic homeostasis of the body. However, in many cases, malignant progression is accompanied by significant immunosuppression, which hinders an effective antitumor response and the elimination of neoplastic cells. The data accumulated over the past decades regarding the mechanisms by which tumors evade immune surveillance have been systematized and integrated into the concept of the \u201cThree Cs\u201c: \u201cCamouflage,\u201d \u201cCoercion,\u201d and \u201cCytoprotection.\u201d<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/en.iepor.site\/wp-content\/uploads\/2025\/06\/\u0417\u0430\u0434\u0432\u043e\u0440\u043d\u0438\u0439.png\" alt=\"Taras Zadvornyi\" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Taras Zadvornyi<\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\nPhD, Senior Researcher,<br \/>\nDepartment of Cytomorphology and Molecular Biological Markers of Tumor Growth,<br \/>\nR.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology,<br \/>\nNational Academy of Sciences of Ukraine\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">Tumor-Associated Macrophages as a Target for Antitumor Therapy<\/h4>\n<p>The metabolic plasticity of macrophages was discovered more than 20 years ago specifically in the context of their involvement in the tumor process. Since then, the concept of functional polarization of macrophages has undergone significant changes due to the expanded understanding of their origin, biological properties, and roles in numerous physiological and pathological processes. The lecture examines the origin and functions of tumor-associated macrophages (TAMs), analyzes the main therapeutic approaches targeting TAMs in cancer treatment, and outlines the prospects of using TAMs in adoptive immunotherapy of oncological diseases.<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/en.iepor.site\/wp-content\/uploads\/2025\/06\/\u0421\u043a\u0456\u0432\u043a\u0430.png\" alt=\"Larysa Skivka\" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Larysa Skivka<\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\nDoctor of Biological Sciences, Professor,<br \/>\nHead of the Department of Microbiology and Immunology, <br \/>\nESC &#171;Institute of Biology and Medicine&#187;, Taras Shevchenko National University of Kyiv\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">From Sample to Conclusion: The Path of Histological Examination<\/h4>\n<p>Key stages of histological examination, from the collection of biological material to the formation of a pathological-histological diagnosis. You will learn about the processes of fixation, tissue processing, embedding, microtomy, staining, and the microscopic analysis of histological samples. The lecture will highlight the role of histology in disease diagnosis, important nuances at each stage of practical research, and the significance of histopathology in modern medicine and its contribution to patient treatment.<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/www.iepor.site\/wp-content\/uploads\/2025\/04\/\u0412\u043e\u0440\u043e\u043d\u0456\u043d.png\" alt=\"Dmytro Voronin\" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Dmytro Voronin<\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\n                PhD Student, Department of Tumor Process Monitoring and Therapy Design<br \/>\n                R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology,<br \/>\n                National Academy of Sciences of Ukraine<br \/>\n                <strong>Pathologist<\/strong>\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">Cytochemical Methods in the Diagnosis and Study of Oncogenesis<\/h4>\n<p>The aim of this review presentation is to explore the modern capabilities and limitations of cytochemical methods in the classification and differential diagnosis of certain tumor diseases, as well as in experimental studies of the biochemical\/metabolic atypia of tumor cells.<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/www.iepor.site\/wp-content\/uploads\/2025\/04\/\u041e\u0441\u0442\u0440\u043e\u0432\u0441\u044c\u043a\u0430.png\" alt=\"Ostrovska Galyna\" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Ostrovska Galyna<\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\n                Doctor of Biological Sciences, Professor<br \/>\n                Department of Cytology, Histology, and Reproductive Medicine<br \/>\n                ESC &#171;Institute of Biology and Medicine&#187;<br \/>\n                Taras Shevchenko National University of Kyiv\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">Mechanisms of Drug Resistance in Malignant Neoplasms: Modern Perspectives<\/h4>\n<p>This lecture focuses on one of the most pressing issues in oncology\u2014the development of a drug-resistant phenotype in malignant transformed cells. We will examine various mechanisms underlying this phenomenon, including changes in the expression of genes encoding transport proteins, detoxification enzymes, and other key molecules. Additionally, we will discuss the latest approaches aimed at overcoming resistance and enhancing the effectiveness of chemotherapy.<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/www.iepor.site\/wp-content\/uploads\/2025\/04\/\u0411\u043e\u0440\u0456\u043a\u0443\u043d.png\" alt=\"Tetiana Borikun\" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Tetiana Borikun<\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\n                PhD in Biological Sciences<br \/>\n                Research Fellow<br \/>\n                Department of Tumor Process Monitoring and Therapy Design<br \/>\n                R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology<br \/>\n                National Academy of Sciences of Ukraine\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div style=\"display: flex; flex-wrap: wrap; border: 1px solid #ccc; padding: 20px; margin-bottom: 30px; font-family: Arial, sans-serif;\">\n<div style=\"flex: 1 1 60%; min-width: 250px; padding-right: 20px;\">\n<h4 style=\"color: #003366; font-size: 18px; font-weight: bold; margin-top: 0;\">Resistance in Clinical Oncology Practice: Modern Challenges and Innovative Approaches<\/h4>\n<p>Therapeutic resistance is one of the key challenges in modern oncology, significantly affecting treatment efficacy and disease prognosis. The issues of primary and acquired resistance are reshaping treatment strategies, emphasizing the use of targeted therapy, immunotherapy, and combination treatment regimens to prevent disease progression. A crucial aspect in overcoming resistance is personalized medicine, which focuses on optimizing treatment strategies based on the molecular profile of tumors.<\/p>\n<\/p><\/div>\n<div style=\"flex: 1 1 35%; min-width: 200px; text-align: center;\">\n                <img decoding=\"async\" src=\"https:\/\/www.iepor.site\/wp-content\/uploads\/2025\/04\/\u041c\u0430\u0440\u0442\u0438\u043d\u044e\u043a.png\" alt=\"Olena Martyniuk\" style=\"width: 180px; height: 180px; object-fit: cover; border-radius: 50%; margin-bottom: 15px;\"><\/p>\n<h5 style=\"color: #003366; margin: 10px 0 5px; font-size: 18px;\">Olena Martyniuk<\/h5>\n<p style=\"margin: 0; font-size: 14px;\">\n                Clinical Oncologist<br \/>\n                Scientific and Clinical Department of Breast Tumors and Reconstructive Surgery<br \/>\n                National Cancer Institute, Kyiv, Ukraine\n                <\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ABOUT THE PROJECT The ONcoLogi\u0421a project is an initiative by the Council of Young Scientists at the R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology of the National Academy of Sciences of Ukraine. It aims to promote modern knowledge and advancements in oncology. The project&#8217;s goal is to unite researchers, doctors, postgraduate students, as [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":27,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-358","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/en.iepor.site\/index.php?rest_route=\/wp\/v2\/pages\/358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/en.iepor.site\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/en.iepor.site\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/en.iepor.site\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/en.iepor.site\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=358"}],"version-history":[{"count":9,"href":"https:\/\/en.iepor.site\/index.php?rest_route=\/wp\/v2\/pages\/358\/revisions"}],"predecessor-version":[{"id":499,"href":"https:\/\/en.iepor.site\/index.php?rest_route=\/wp\/v2\/pages\/358\/revisions\/499"}],"up":[{"embeddable":true,"href":"https:\/\/en.iepor.site\/index.php?rest_route=\/wp\/v2\/pages\/27"}],"wp:attachment":[{"href":"https:\/\/en.iepor.site\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}